179 related articles for article (PubMed ID: 1282105)
21. Antiallergic effects of 4-[2-oxo-3-(1H-tetrazol-5-yl)-2H-chromen-8-yloxy]-bu tyric acid.
Kuriyama K; Hiyama Y; Ito K
Jpn J Pharmacol; 1989 Jun; 50(2):111-8. PubMed ID: 2475659
[TBL] [Abstract][Full Text] [Related]
22. Immediate inhibitory effect of methylprednisolone suleptanate (U-67590A) on antigen-induced cutaneous and airway anaphylactic responses in guinea-pigs.
Hashimoto M; Shinozaki Y; Katori M
Br J Pharmacol; 1993 Mar; 108(3):604-12. PubMed ID: 7682130
[TBL] [Abstract][Full Text] [Related]
23. Bronchoprotective effects of KF-19514 and cilostazol in guinea pigs in vivo.
Fujimura M; Kita T; Myou S; Tachibana H; Matsuda T
Eur J Pharmacol; 1997 May; 327(1):57-63. PubMed ID: 9185836
[TBL] [Abstract][Full Text] [Related]
24. Antiallergic/antiasthmatic activity of oligopeptide related to IgE.
Singh R; Nath A; Gupta PP; Shulka M; Khare SK; Kundu B
Pharmacol Res; 1998 May; 37(5):353-6. PubMed ID: 9642030
[TBL] [Abstract][Full Text] [Related]
25. Antiallergic activity profile in vitro of RHC 2963 and related compounds.
Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Youssefyeh RD
Int J Immunopharmacol; 1983; 5(6):491-502. PubMed ID: 6198298
[TBL] [Abstract][Full Text] [Related]
26. Anti-anaphylactic activities of a new benzopyranopyridine derivative Y-12,141 in rats and guinea pigs.
Goto K; Terasawa M; Kadobe Y; Maruyama Y
Jpn J Pharmacol; 1980 Aug; 30(4):537-47. PubMed ID: 6162988
[TBL] [Abstract][Full Text] [Related]
27. Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig.
Underwood DC; Bochnowicz S; Osborn RR; Kotzer CJ; Luttmann MA; Hay DW; Gorycki PD; Christensen SB; Torphy TJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):988-95. PubMed ID: 9864284
[TBL] [Abstract][Full Text] [Related]
28. [Antiallergic effects of a novel compound, SWR-00151].
Tanaka Y; Masai E; Yashima T; Furukawa M
Nihon Yakurigaku Zasshi; 1997 Apr; 109(4):193-206. PubMed ID: 9160349
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological studies on BB-1502, a new bronchodilator.
Kamei H; Hirano M; Kawano K; Murata S; Imanishi H; Kawaguchi H
Jpn J Pharmacol; 1981 Jun; 31(3):333-46. PubMed ID: 6273627
[TBL] [Abstract][Full Text] [Related]
30. The pharmacologic profile of wy-41,195, a new orally effective antiallergic agent.
Carlson RP; Dervinis A; DiLuigi JM; Capetola RJ; Rosenthale ME; Lewis AJ
Arzneimittelforschung; 1982; 32(12):1546-53. PubMed ID: 6186261
[TBL] [Abstract][Full Text] [Related]
31. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
Tasaka K; Akagi M; Izushi K; Mio M
Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacological studies on KW-4679, an antiallergic drug. (1): Inhibitory effect on passive cutaneous anaphylaxis (PCA) and experimental asthma in rats and guinea pigs].
Ishii H; Sasaki Y; Ikemura T; Kitamura S; Ohmori K
Nihon Yakurigaku Zasshi; 1995 Oct; 106(4):289-98. PubMed ID: 8537076
[TBL] [Abstract][Full Text] [Related]
33. The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.
Hughes B; Howat D; Lisle H; Holbrook M; James T; Gozzard N; Blease K; Hughes P; Kingaby R; Warrellow G; Alexander R; Head J; Boyd E; Eaton M; Perry M; Wales M; Smith B; Owens R; Catterall C; Lumb S; Russell A; Allen R; Merriman M; Bloxham D; Higgs G
Br J Pharmacol; 1996 Jul; 118(5):1183-91. PubMed ID: 8818342
[TBL] [Abstract][Full Text] [Related]
34. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
Yamamura H; Kohno S; Ohata K
Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
[TBL] [Abstract][Full Text] [Related]
35. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
[TBL] [Abstract][Full Text] [Related]
36. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
Yanagihara Y; Abe T; Edanami K; Agata M; Kuroda T; Shida T
Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
[TBL] [Abstract][Full Text] [Related]
37. Peptide leukotriene antagonistic activity of AS-35, a new antiallergic drug.
Kasai H; Kawashima T; Omura S; Yanagihara Y
Jpn J Pharmacol; 1992 Apr; 58(4):347-55. PubMed ID: 1405032
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological studies on the novel antiallergic drug HQL-79: I. Antiallergic and antiasthmatic effects in various experimental models.
Matsushita N; Hizue M; Aritake K; Hayashi K; Takada A; Mitsui K; Hayashi M; Hirotsu I; Kimura Y; Tani T; Nakajima H
Jpn J Pharmacol; 1998 Sep; 78(1):1-10. PubMed ID: 9804056
[TBL] [Abstract][Full Text] [Related]
39. Studies on a new antiallergic pyridinecarboxamide TA-5707F and its sodium salt (TA-5707). II. Mechanism of antiallergic action of TA-5707.
Tsuzurahara K; Ishikawa S; Ono Y; Murata T; Kikuchi M; Takeyama S
Jpn J Pharmacol; 1987 Sep; 45(1):55-62. PubMed ID: 2446038
[TBL] [Abstract][Full Text] [Related]
40. Immunopharmacological studies on TBX, a new antiallergic drug (1). Inhibitory effects on passive cutaneous anaphylaxis in rats and guinea pigs.
Yanagihara Y; Kasai H; Kawashima T; Shida T
Jpn J Pharmacol; 1988 Sep; 48(1):91-101. PubMed ID: 2462074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
